Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-25. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.
OPTHF stock price ended at $0.25 on 火曜日, after dropping 3.85%
On the latest trading day Feb 10, 2026, the stock price of OPTHF fell by 3.85%, dropping from $0.25 to $0.25. During the session, the stock saw a volatility of 4.00%, with prices oscillating between a daily low of $0.25 and a high of $0.26. On the latest trading day, the trading volume for OPTHF decreased by 46.3K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 36.2K shares were traded, with a market value of approximately $24.1M.